CAT. NO. DC58312
Product page and current package options
| Parameter | Value |
|---|---|
| Chemical Name | GDC-6036 |
| CAS No. | 2417987-45-0 |
| Synonyms | 1-((S)-4-((R)-7-(6-Amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en-1-one;Divarasib |
| Formula | C29H32ClF4N7O2 |
| M.Wt | 622.06 |
| SMILES | C(=C)C(N1CC(C)N(C2=NC(OCC3N(C)CCC3)=NC3C2=CC(=C(C2N=C(N)C=C(C)C=2C(F)(F)F)C=3F)Cl)CC1)=O |
| Purity | >98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
GDC-6036 is a novel oral KRAS G12C inhibitor.
No in vitro data are provided in the current product source. Contact us for further information.
No in vivo data are provided in the current product source. Contact us for further information.
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.